Calavant-D is primarily indicated in conditions like Acute hypocalcaemia, Hyperphosphataemia, Hypocalcaemia, Hypoparathyroidism, In hypocalcaemic tetany, Osteoporosis prophylaxis, Osteoporosis, if the actual dietary intake less than the RDA, and can also be given in adjunctive therapy as an alternative drug of choice in Blood Pressure, Cardiopulmonary resuscitation, Hypertension, Premenstrual syndrome, Severe hyperkalaemia, Severe hypermagnesaemia.
Calavant-D is contraindicated in conditions like Hypercalcaemia,Hypercalciuria, Renal calculi.
The severe or irreversible adverse effects of Calcium, which give rise to further complications include Hypotension, Hypotension, Sinus bradycardia.Calavant-Dproduces potentially life-threatening effects which include Cardiac arrhythmia, Cardiac Arrest, Cardiac arrest. which are responsible for the discontinuation of Calavant-Dtherapy. The symptomatic adverse reactions produced by Calavant-D are more or less tolerable and if they become severe, they can be treated symptomatically, these include Thirst, Headache, Nausea, Vomiting, Anorexia, Constipation, Abdominal pain, Dry mouth, Confusion, Syncope, Hypophosphatemia, GI irritation, Hypercalcemia, Dry mouth, Confusion.